Project Grant HT94252510587

This $2.9 million Defense Health Agency project grant funds research on suicide prevention among military personnel and veterans. The grant supports a multi-site randomized clinical trial through September 2026 to evaluate the efficacy of Written Exposure Therapy for Suicide Prevention compared to treatment as usual. Researchers at Boston University and partner institutions University of Colorado Denver and University of Texas Health Science Center San Antonio aim to reduce suicidal thoughts and...

This federal Project Grant award of $2,398,281.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program aims to increase access to evidence-based PTSD treatment for military service members and veterans through Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary awardee, Palo Alto Veterans Institute for Research (Pavir), will oversee the overall project objectives, which include providing WET training to...

This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...

This $5,024,305 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to augment Cognitive Processing Therapy (CPT) to prevent suicide risk among patients with PTSD. The grant was awarded to The Ohio State University on June 15, 2024 with a completion date of June 14, 2028. The project includes a sub-award to the University of Texas Health Science Center at San Antonio (UTHSCSA) to leverage the resources of the...

This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,326,715 to the Boston VA Research Institute, Inc. (BVARI) to develop and conduct a preliminary evaluation of a self-directed, internet-based Cognitive Processing Therapy (CPT) intervention. The funding period is from September 1, 2024 to August 31, 2028. The key products and services to be delivered under this grant include: Developing the web-based CPT...

This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...

This federal Project Grant award of $2,993,024.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of lethal means safety counseling for service members and civilians with post-traumatic stress disorder (PTSD). The study, titled "FIREARM SAFETY IN PTSD (FASP): A RANDOMIZED CONTROLLED TRIAL OF LETHAL MEANS SAFETY COUNSELING AMONG SERVICE MEMBERS AND CIVILIANS WITH PTSD", will be conducted by...

This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $5,009,418.00 to The Ohio State University to develop "The Core Competency Model-Military Version (CCM-MV): A Virtual Suicide Prevention Training Program". The project aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. Awarded on September 1, 2025, the project...

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...